Condition
Abdominal Aorta Aneurysm
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Lidocaine
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
Phase 4 (1)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT03974958Not ApplicableCompletedPrimary
Circulating microRNAs and Degenerative Abdominal Aorta Aneurysm
NCT04691726Phase 4CompletedPrimary
Impact of Intra- and Postoperative Continuous Infusion of Lidocaine on Analgesia in Vascular Anaesthesia
NCT01710878Not ApplicableCompletedPrimary
Performance and Safety of a Second Generation Antimicrobial Graft in Abdominal Position
Showing all 3 trials
Research Network
Common Treatments
- Lidocaine1
- Metamizole1
- Tissuelibrary1
- Intergard Synergy Graft1
- Morphine1
Active Sponsors
- Maquet Cardiovascular1
- Assistance Publique Hopitaux De Marseille1
- Łukasz Krzych1
Top Investigators
Medical University of Silesia, Katowice
CHU La Milétrie
Assistance Publique Hôpitaux de Marseille
Related Conditions
- Surgery1
- Abdominal Aorta Atheroma1
- Pain Postoperative1